KNEE JOINT DISORDERS
Knee Joint Disorders
Adipose-derived stem cells support cartilage repair, anti-inflammatory action and functional recovery for chronic knee disease.
SCROLL
Beyond Painkillers and Replacement
Knee Joint Disease Deserves Regenerative, Not Just Palliative, Care
Knee pain, swelling, stiffness and grinding are early signs of cartilage breakdown that often progresses to osteoarthritis. Traditional treatment—medication, injections, surgery or replacement—addresses symptoms but rarely restores the cartilage surface. Stem-cell therapy, particularly local injection of adipose-derived MSCs into the joint, supports chondrocyte regeneration, anti-inflammatory modulation and gradual restoration of joint function.
Why Conventional Knee Therapy Often Fails Long-Term
A deeper, more considered approach
- Painkillers reduce pain but cannot regenerate cartilage.
- Hyaluronic acid injections provide only temporary lubrication.
- Arthroscopic surgery cannot fully restore damaged cartilage.
- Knee replacement involves long recovery and limited lifespan.
- Patients face progressive loss of mobility and independence.
Cartilage & Joint Repair
Why Stem-Cell Therapy Is Changing Knee Joint Care
Anti-Inflammatory Synovial Effect
Stem cells reduce synovial inflammation, lowering swelling and effusion.Joint Microenvironment Improvement
Trophic factors restore synovial fluid quality and cartilage matrix metabolism.Minimally Invasive Local Injection
Cells are delivered via intra-articular injection — no surgery, no general anesthesia.Compatible with PRP Therapy
May be combined with PRP to create a favorable regenerative environment before stem-cell delivery.Lower Long-Term Joint Risk
May delay or avoid the need for total knee replacement in selected patients.Clinical Improvements
Improvements Patients May Experience
- Marked reduction in walking and stair-climbing pain
- Reduced swelling and joint effusion within weeks
- Improved range of motion and joint flexibility
- Visible cartilage thickening on follow-up MRI
- Ability to discontinue canes, walkers or wheelchairs
Suitable Candidates
Designed for individual needs
- Patients with mild to moderate knee osteoarthritis (K-L grade 2-3)
- Patients with meniscus injury who want to preserve the joint
- Post-knee-surgery patients with residual pain
- Middle-aged and elderly patients hoping to delay joint replacement
- Athletes with cartilage damage from sports overuse
Patient Stories
Observed changes and clinical stories
Stage-4 Knee Osteoarthritis — Elderly Patient
An 88-year-old woman with stage-4 knee osteoarthritis received a single autologous stem-cell injection. Walking ability and pain both improved markedly in follow-up.Middle-Aged Patient Avoiding Replacement
A 71-year-old female with bilateral severe knee pain avoided total knee replacement after stem-cell therapy and returned to daily walking.Private, professional, precise